Cipher Pharmaceuticals (OTCMKTS:CPHRF) Stock Price Passes Above 50-Day Moving Average – Here’s What Happened

by · The Markets Daily

Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF – Get Free Report) (TSE:CPH)’s stock price crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $11.42 and traded as high as $12.79. Cipher Pharmaceuticals shares last traded at $12.35, with a volume of 90,126 shares.

Cipher Pharmaceuticals Stock Up 1.3 %

The firm’s 50 day moving average is $11.49 and its two-hundred day moving average is $8.20.

About Cipher Pharmaceuticals

(Get Free Report)

Cipher Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution indicated for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp; Ozanex for the topical treatment of impetigo; Vaniqa, a topical cream for the slowing of the growth of unwanted facial hair in women; Durela, an opioid analgesic for the management of moderate to moderately severe pain in adults; Brinavess for the rapid conversion of onset atrial fibriallation to sinus rhythm in adults; and Aggrastat, a reversible GP IIb/IIIa inhibitor for use in patients with Acute Coronary Syndrome.

Further Reading